Caricamento...
In vivo–activated CD103(+)CD4(+) regulatory T cells ameliorate ongoing chronic graft-versus-host disease
CD103 (αEβ7) has been shown to be an excellent marker for identifying in vivo–activated FoxP3(+)CD4(+) regulatory T (Treg) cells. It is unknown whether reinfusion of in vivo–activated donor-type CD103(+) Treg cells from recipient can ameliorate ongoing chronic graft-versus-host disease (GVHD). Here,...
Salvato in:
| Autori principali: | , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society of Hematology
2008
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2518910/ https://ncbi.nlm.nih.gov/pubmed/18550852 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-02-140277 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|